ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Moleculin Biotech (MBRX) Technical (Analysis) Reports Moleculin Biotech ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Moleculin Biotech (MBRX)

Technical Analysis Report for USA stock MBRX Moleculin Biotech. Dated: 16 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange

If you are looking for Tomorrow's Movement Predictions for USA stock MBRX Moleculin Biotech then click here. or read Experts views on Moleculin Biotech or Forecast & share price targets of Moleculin Biotech

Moleculin Biotech Opened at 4.47 and Closed at: 4.69, which is 4.05% of previous session's close. It moved within a range of 4.36 and 4.78
The session was a Bullish session with an average volume of 103200, which is -62.69% of previous session's volumes.

  • The stock has shown an up move, and its short term trend is also positive and in an uptrend.
  • The stock has shown an up move, and its mid term trend is also positive and in an uptrend.
  • The stock has shown an up move, and its long term trend is also positive and in an uptrend.

Support for tomorrow is 4.53 and resistance for tomorrow is 4.95
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 4.44, 4.19 resistance for tomorrow's hourly charts is 4.86, 5.03

10 Day SMA for Moleculin Biotech (MBRX) is 6.04 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Moleculin Biotech (MBRX) is 3.83 and the stock is trading above these levels. This is a good sign for its mid term trend

50 Day SMA for Moleculin Biotech (MBRX) is 1.82 and the stock is trading above these levels. This is a good sign for its mid to long term trend

100 Day SMA is 1.17 and the stock is trading above these levels. This is a good sign for its long term trend

200 Day SMA Moleculin Biotech is 1 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Moleculin Biotech is at 3.83 and 200 DMA is at 1, while 50 DMA and 100 DMA are at 1.82 and 1.17 respectively

Moleculin Biotech (MBRX) moving average of 20 SMA is at 3.83 and 20 EMA is at 4.18

Moleculin Biotech (MBRX) moving average of 50 SMA is at 1.82 and 50 EMA is at 2.59

Moleculin Biotech (MBRX) moving average of 100 SMA is at 1.17 and 100 EMA is at 1.78

Moleculin Biotech (MBRX) moving average of 200 SMA is at 1 and 200 EMA is at 1.49

Moleculin Biotech has performed better than Zimmer Biomet in short term. Holding Moleculin Biotech could be a better choice for now!

Moleculin Biotech has performed better than Dr Reddy in short term. Holding Moleculin Biotech could be a better choice for now!

Moleculin Biotech has performed better than Merck Company in short term. Holding Moleculin Biotech could be a better choice for now!

Moleculin Biotech has performed better than Mednax Inc in short term. Holding Moleculin Biotech could be a better choice for now!

Moleculin Biotech has performed better than Glaxosmithkline Plc in short term. Holding Moleculin Biotech could be a better choice for now!

Moleculin Biotech has performed better than Neuronetics Inc in short term. Holding Moleculin Biotech could be a better choice for now!

Moleculin Biotech has performed better than Sellas Life in short term. Holding Moleculin Biotech could be a better choice for now!

Moleculin Biotech has performed better than Regeneron Pharmaceuticals in short term. Holding Moleculin Biotech could be a better choice for now!

Moleculin Biotech has performed better than Protagonist Therapeutics in short term. Holding Moleculin Biotech could be a better choice for now!

Moleculin Biotech has performed better than Insulet Corporation in short term. Holding Moleculin Biotech could be a better choice for now!

Moleculin Biotech has performed better than Novavax Inc in short term. Holding Moleculin Biotech could be a better choice for now!

Moleculin Biotech has performed better than Moderna Inc in short term. Holding Moleculin Biotech could be a better choice for now!

Moleculin Biotech has performed better than Jazz Pharmaceuticals in short term. Holding Moleculin Biotech could be a better choice for now!

Moleculin Biotech has performed better than Harrow Health in short term. Holding Moleculin Biotech could be a better choice for now!

Moleculin Biotech has performed better than Gossamer Bio in short term. Holding Moleculin Biotech could be a better choice for now!

Moleculin Biotech has performed better than Collegium Pharmaceutical in short term. Holding Moleculin Biotech could be a better choice for now!

Moleculin Biotech has performed better than Coherus Biosciences in short term. Holding Moleculin Biotech could be a better choice for now!

Moleculin Biotech has performed better than Accuray Incorporated in short term. Holding Moleculin Biotech could be a better choice for now!

Moleculin Biotech has performed better than Anika Therapeutics in short term. Holding Moleculin Biotech could be a better choice for now!

Moleculin Biotech Technical analysis of indicators

Price action analysis of Moleculin Biotech (MBRX) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Moleculin Biotech stock for short term is BUY. Signal strength is Weak and stock is losing momentum.

MACD generated a SELL signal for Moleculin Biotech in short term but the sell signal is initial and weak.

Moleculin Biotech Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.

Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up

CCI has generated a SELL signal for Moleculin Biotech in short term and SELL signal is strong!

RSI is generating a BUY signal in short term but buying is losing momentum.

MRSI is in positive zone. This is a BUY zone

Although the stock is in the BUY zone, but buying might be slowing down

Stock of Moleculin Biotech is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 6.29 and Moleculin Biotech MBRX stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Moleculin Biotech MBRX stock. Volume based technical analysis of Moleculin Biotech MBRX stock is negative.

Moleculin Biotech Stock has given negative returns over a short term period. Returns for a longer term period have been positive

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for USA stock MBRX Moleculin Biotech These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And MBRX Experts View which covers a lot of information including buying and selling signals

MBRX future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Moleculin Biotech or View Candle Stick Charts here

Chart Moleculin Biotech (MBRX)  Technical (Analysis) Reports Moleculin Biotech [

Videos related to: Moleculin Biotech (MBRX) Technical (Analysis) Reports Moleculin Biotech ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Moleculin Biotech (MBRX)  Technical (Analysis) Reports Moleculin Biotech [

 

Back to top